Why Akums Drugs IPO needs your attention? | Akums Drugs & Pharmaceuticals Ltd IPO Review

Akums Drugs and Pharmaceuticals IPO opens for subscription on July 30, 2024 and closes on August 1, 2024. Akums Drugs and Pharmaceuticals Ltd IPO is a mainboard IPO. Should you invest or avoid? In this Akums Drugs & Pharmaceuticals Ltd IPO Review video we will discuss points like company's financials, business model and more! Subscribe to us if you find our Akums Drugs and Pharmaceuticals Ltd IPO analysis video informative!

About Akums Drugs & Pharmaceuticals Ltd:

Akums Drugs and Pharmaceuticals Limited is a leading Contract Development and Manufacturing Organization (CDMO) in India's pharmaceutical industry. Since its inception in 2004, the company has been dedicated to providing comprehensive solutions for product development and manufacturing. With a strong emphasis on quality and compliance, Akums has established itself as a trusted partner for pharmaceutical companies seeking reliable and efficient services. The company's expertise spans a wide range of products, catering to both domestic and international markets.

More Akums Drugs & Pharmaceuticals Ltd IPO Details:

Akums Drugs and Pharmaceuticals IPO price band is set at ₹646 to ₹679 per share. The minimum lot size for an application is 22 Shares. The minimum amount of investment required by retail investors is ₹14,938. The minimum lot size investment for sNII is 14 lots (308 shares), amounting to ₹209,132, and for bNII, it is 67 lots (1,474 shares), amounting to ₹1,000,846.

Join Us For all the latest updates about startups, preipo and unicorns.

Keep yourself updated with the market situation.

Join us on Facebook​

LinkedIN​

Twitter​

Instagram​

Telegram​

Contact us at +91 7065560002 via Whatsapp/Normal call

Or Mail us at help@planify.in

⬇️ Download the app for easy access. Links are given below:

​Planify iPhone App​

​Planify Android App